Isleworth Healthcare Acquisition Corporation Common stock
ISLE
ISLE was delisted on the 26th of August, 2022.
0 hedge funds and large institutions have $0 invested in Isleworth Healthcare Acquisition Corporation Common stock in 2022 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 70 closing their positions.
100% less funds holding
Funds holding: 70 → 0 (-70)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
100% less capital invested
Capital invested by funds: $179M → $0 (-$179M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 70
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GCL
Glazer Capital LLC
New York
|
-$15.1M |
| 2 |
PC
Periscope Capital
Toronto,
Ontario, Canada
|
-$13.6M |
| 3 |
D.E. Shaw & Co
New York
|
-$11.6M |
| 4 |
BL
Bleichroeder LP
New York
|
-$9.96M |
| 5 |
WRBC
W.R. Berkley Corp
Greenwich,
Connecticut
|
-$8.79M |
ISLE Hedge Fund Activity: Q3 2022 in Review
0 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Isleworth Healthcare Acquisition Corporation Common stock (ISLE) for Q3 2022, worth a combined $0 — down 100% from $179M a quarter earlier.
Sellers outnumbered buyers: 70 funds closed out of ISLE and 0 opened new positions — a net loss of 70 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Glazer Capital LLC, exiting entirely with an estimated $15.1M sold.
- 0 institutional investors held Isleworth Healthcare Acquisition Corporation Common stock (ISLE) as of Q3 2022, down from 70 in Q2 2022.
- Funds reported $0 of Isleworth Healthcare Acquisition Corporation Common stock stock for Q3 2022, down 100% quarter-over-quarter.
- 0 funds opened new Isleworth Healthcare Acquisition Corporation Common stock positions in Q3 2022 and 70 closed out, a net change of -70 holders.
- The largest Isleworth Healthcare Acquisition Corporation Common stock seller in Q3 2022 was Glazer Capital LLC, an estimated $15.1M sold.
Based on aggregated 13F filings for Q3 2022.